No Data
No Data
Emerging markets stock digest: Jelbins significantly extended, Rainfall Sunlight hit the daily limit
<150A> JSH 621 -1 deadlock. It has been announced that a new branch of the home medical care business, 'Visiting Nurse Station Cordiale Edogawa Sales Office,' has been established in Edogawa-ku, Tokyo. 'Visiting Nurse Station Cordiale' is a psychiatric home visit medical support service office. The number of psychiatric patients is increasing year by year, and the demand for home medical care that can be received at home is expanding, so efforts are being made to expand the area. <206A> PRISMBio 415 -39
JSH surged significantly, opening a new base for home medical care business in Edogawa, Tokyo.
Sharply rebounded. Selling pressure prevailed in the morning, but later buying back has become dominant. It has been announced that a new base for home medical care business, 'Visiting Nursing Station Cordiale Edogawa Sales Office,' has been opened in Edogawa Ward, Tokyo. 'Visiting Nursing Station Cordiale' is a psychiatric home visit medical support service facility. The number of psychiatric patients is increasing year by year, and the demand for home medical care that can be received at home is expanding, so it aims to expand the area.
JSH Research Memo (9): Prioritize the enhancement of internal reserves in the near term and continue with no dividends.
The shareholder return policy JSH <150A> positions shareholder returns as one of the important management issues, but as of the end of March 2024, retained earnings are negative at 4.32 billion yen. Therefore, the decision is to continue with no distribution for the time being in order to enhance corporate value through the enhancement of internal reserves. There is a high possibility that retained earnings will turn positive by the end of March 2027, but the policy is to determine the timing of dividend commencement comprehensively based on performance, financial situation, capital needs, etc. (Writing)
JSH Research Memo (7): The performance for the fiscal year ending March 2025 is expected to continue its double-digit growth driven by the support for employing persons with disabilities.
The performance for the fiscal year ending March 2025 is expected to achieve double-digit growth in revenue with a 18.1% increase to 41.11 billion yen, a 24.2% increase in operating profit to 2.58 billion yen, a 31.5% increase in ordinary profit to 2.56 billion yen, and a 32.6% increase in net income to 1.92 billion yen, marking the highest performance in history.
JSH Research Memo (6): Funds raised through the stock listing will be used for growth investment.
■JSH＜150A＞ Performance Trends 2. Financial Position and Management Indicators As of the end of March 2024, the financial position shows total assets increased by 546 million yen compared to the previous period to 2,539 million yen. Current assets increased by 393 million yen primarily due to capital increases related to stock market listings, including cash and deposits, and accounts receivable and contract assets increased by 104 million yen. Fixed assets increased by 46 million yen primarily due to the establishment of new farms. Total liabilities increased by 44 million yen compared to the previous period to 705 million yen. Interest-bearing liabilities were
JSH Research Memo (5): The performance for the March 2024 period is expected to achieve a new record high, excluding net income.
Performance Trends of JSH＜150A＞1. Performance Overview for the fiscal year ended March 2024 In the fiscal year ended March 2024, revenue increased by 17.3% year-on-year to 34.82 billion yen, operating profit increased by 26.5% to 2.08 billion yen, ordinary profit increased by 21.2% to 1.94 billion yen, and net income decreased by 22.6% to 1.45 billion yen. Although net income decreased due to tax burden, revenue, operating profit, and ordinary profit all reached record highs thanks to the growth of regional revitalization business.
No Data
No Data